Similarities between Benign prostatic hyperplasia and Urinary retention
Benign prostatic hyperplasia and Urinary retention have 42 things in common (in Unionpedia): Alpha blocker, Alpha-adrenergic agonist, Anticholinergic, Antihistamine, Bladder cancer, Bladder stone, Calcium channel blocker, Cancer, Catheter, Decongestant, Diabetes mellitus, Dihydrotestosterone, Dutasteride, Finasteride, Hydronephrosis, Hypertension, Kidney failure, Libido, Lower urinary tract symptoms, Meta-analysis, Muscarinic antagonist, Nocturia, Opioid, Parkinson's disease, Prostate cancer, Prostate-specific antigen, Prostatectomy, Spinal cord injury, Tamsulosin, Terazosin, ..., Testosterone, Transurethral resection of the prostate, Tricyclic antidepressant, Urethra, Urethral stricture, Urinary bladder, Urinary catheterization, Urinary incontinence, Urinary tract infection, Urodynamic testing, Urology, 5α-Reductase inhibitor. Expand index (12 more) »
Alpha blocker
Alpha-blockers, also known as α-blockers or α-adrenoreceptor antagonists, are a class of pharmacological agents that act as antagonists on α-adrenergic receptors (α-adrenoceptors).
Alpha blocker and Benign prostatic hyperplasia · Alpha blocker and Urinary retention ·
Alpha-adrenergic agonist
Adrenergic alpha-agonists (or alpha-adrenergic agonists) are a class of sympathomimetic agents that selectively stimulates alpha adrenergic receptors.
Alpha-adrenergic agonist and Benign prostatic hyperplasia · Alpha-adrenergic agonist and Urinary retention ·
Anticholinergic
An anticholinergic agent is a substance that blocks the neurotransmitter acetylcholine in the central and the peripheral nervous system.
Anticholinergic and Benign prostatic hyperplasia · Anticholinergic and Urinary retention ·
Antihistamine
Antihistamines are drugs which treat allergic rhinitis and other allergies.
Antihistamine and Benign prostatic hyperplasia · Antihistamine and Urinary retention ·
Bladder cancer
Bladder cancer is any of several types of cancer arising from the tissues of the urinary bladder.
Benign prostatic hyperplasia and Bladder cancer · Bladder cancer and Urinary retention ·
Bladder stone
A bladder stone is a stone found in the urinary bladder.
Benign prostatic hyperplasia and Bladder stone · Bladder stone and Urinary retention ·
Calcium channel blocker
Calcium channel blockers (CCB), calcium channel antagonists or calcium antagonists are several medications that disrupt the movement of calcium through calcium channels.
Benign prostatic hyperplasia and Calcium channel blocker · Calcium channel blocker and Urinary retention ·
Cancer
Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body.
Benign prostatic hyperplasia and Cancer · Cancer and Urinary retention ·
Catheter
In medicine, a catheter is a thin tube made from medical grade materials serving a broad range of functions.
Benign prostatic hyperplasia and Catheter · Catheter and Urinary retention ·
Decongestant
A decongestant, or nasal decongestant, is a type of pharmaceutical drug that is used to relieve nasal congestion in the upper respiratory tract.
Benign prostatic hyperplasia and Decongestant · Decongestant and Urinary retention ·
Diabetes mellitus
Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period.
Benign prostatic hyperplasia and Diabetes mellitus · Diabetes mellitus and Urinary retention ·
Dihydrotestosterone
Dihydrotestosterone (DHT), or 5α-dihydrotestosterone (5α-DHT), also known as androstanolone or stanolone, is an endogenous androgen sex steroid and hormone.
Benign prostatic hyperplasia and Dihydrotestosterone · Dihydrotestosterone and Urinary retention ·
Dutasteride
Dutasteride, sold under the brand name Avodart among others, is a medication used primarily to treat enlarged prostate in men.
Benign prostatic hyperplasia and Dutasteride · Dutasteride and Urinary retention ·
Finasteride
Finasteride, sold under the brand names Proscar and Propecia among others, is a medication used mainly to treat an enlarged prostate or scalp hair loss in men.
Benign prostatic hyperplasia and Finasteride · Finasteride and Urinary retention ·
Hydronephrosis
Hydronephrosis describes urine-filled dilation of the renal pelvis and/or calyces as a result of obstruction.
Benign prostatic hyperplasia and Hydronephrosis · Hydronephrosis and Urinary retention ·
Hypertension
Hypertension (HTN or HT), also known as high blood pressure (HBP), is a long-term medical condition in which the blood pressure in the arteries is persistently elevated.
Benign prostatic hyperplasia and Hypertension · Hypertension and Urinary retention ·
Kidney failure
Kidney failure, also known as end-stage kidney disease, is a medical condition in which the kidneys no longer work.
Benign prostatic hyperplasia and Kidney failure · Kidney failure and Urinary retention ·
Libido
Libido, colloquially known as sex drive, is a person's overall sexual drive or desire for sexual activity.
Benign prostatic hyperplasia and Libido · Libido and Urinary retention ·
Lower urinary tract symptoms
Lower urinary tract symptoms (LUTS) refer to a group of clinical symptoms involving the bladder, urinary sphincter, urethra, and, in men, the prostate.
Benign prostatic hyperplasia and Lower urinary tract symptoms · Lower urinary tract symptoms and Urinary retention ·
Meta-analysis
A meta-analysis is a statistical analysis that combines the results of multiple scientific studies.
Benign prostatic hyperplasia and Meta-analysis · Meta-analysis and Urinary retention ·
Muscarinic antagonist
A muscarinic receptor antagonist (MRA) is a type of anticholinergic agent that blocks the activity of the muscarinic acetylcholine receptor.
Benign prostatic hyperplasia and Muscarinic antagonist · Muscarinic antagonist and Urinary retention ·
Nocturia
Nocturia (derived from Latin nox, night, and Greek ούρα, urine), also called nycturia (Greek νυκτουρία), is defined by the International Continence Society (ICS) as “the complaint that the individual has to wake at night one or more times for voiding (i.e. to urinate).” Its causes are varied and, in many patients, difficult to discern.
Benign prostatic hyperplasia and Nocturia · Nocturia and Urinary retention ·
Opioid
Opioids are substances that act on opioid receptors to produce morphine-like effects.
Benign prostatic hyperplasia and Opioid · Opioid and Urinary retention ·
Parkinson's disease
Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.
Benign prostatic hyperplasia and Parkinson's disease · Parkinson's disease and Urinary retention ·
Prostate cancer
Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system.
Benign prostatic hyperplasia and Prostate cancer · Prostate cancer and Urinary retention ·
Prostate-specific antigen
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene. PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland. PSA is produced for the ejaculate, where it liquefies semen in the seminal coagulum and allows sperm to swim freely. It is also believed to be instrumental in dissolving cervical mucus, allowing the entry of sperm into the uterus. PSA is present in small quantities in the serum of men with healthy prostates, but is often elevated in the presence of prostate cancer or other prostate disorders. PSA is not a unique indicator of prostate cancer, but may also detect prostatitis or benign prostatic hyperplasia.
Benign prostatic hyperplasia and Prostate-specific antigen · Prostate-specific antigen and Urinary retention ·
Prostatectomy
Prostatectomy (from the Greek prostates, "prostate", combined with the suffix -ektomē, "excision") as a medical term refers to the surgical removal of all or part of the prostate gland.
Benign prostatic hyperplasia and Prostatectomy · Prostatectomy and Urinary retention ·
Spinal cord injury
A spinal cord injury (SCI) is damage to the spinal cord that causes temporary or permanent changes in its function.
Benign prostatic hyperplasia and Spinal cord injury · Spinal cord injury and Urinary retention ·
Tamsulosin
Tamsulosin, sold under the trade name Alna ® / Flomax ®, is a medication used to treat symptomatic benign prostatic hyperplasia (BPH) and chronic prostatitis, help with the passage of kidney stones, and for urinary retention along with other measures.
Benign prostatic hyperplasia and Tamsulosin · Tamsulosin and Urinary retention ·
Terazosin
Terazosin (marketed as Hytrin or Zayasel) is a selective alpha-1 antagonist used for treatment of symptoms of an enlarged prostate (BPH).
Benign prostatic hyperplasia and Terazosin · Terazosin and Urinary retention ·
Testosterone
Testosterone is the primary male sex hormone and an anabolic steroid.
Benign prostatic hyperplasia and Testosterone · Testosterone and Urinary retention ·
Transurethral resection of the prostate
Transurethral resection of the prostate (commonly known as a TURP, plural TURPs, and rarely as a transurethral prostatic resection, TUPR) is a urological operation.
Benign prostatic hyperplasia and Transurethral resection of the prostate · Transurethral resection of the prostate and Urinary retention ·
Tricyclic antidepressant
Tricyclic antidepressants (TCAs) are a class of medications that are used primarily as antidepressants.
Benign prostatic hyperplasia and Tricyclic antidepressant · Tricyclic antidepressant and Urinary retention ·
Urethra
In anatomy, the urethra (from Greek οὐρήθρα – ourḗthrā) is a tube that connects the urinary bladder to the urinary meatus for the removal of urine from the body.
Benign prostatic hyperplasia and Urethra · Urethra and Urinary retention ·
Urethral stricture
A urethral stricture is a narrowing of the urethra caused by injury, instrumentation, infection and certain non-infectious forms of urethritis.
Benign prostatic hyperplasia and Urethral stricture · Urethral stricture and Urinary retention ·
Urinary bladder
The urinary bladder is a hollow muscular organ in humans and some other animals that collects and stores urine from the kidneys before disposal by urination.
Benign prostatic hyperplasia and Urinary bladder · Urinary bladder and Urinary retention ·
Urinary catheterization
In urinary catheterization a latex, polyurethane, or silicone tube known as a urinary catheter is inserted into a patient's bladder via the urethra.
Benign prostatic hyperplasia and Urinary catheterization · Urinary catheterization and Urinary retention ·
Urinary incontinence
Urinary incontinence (UI), also known as involuntary urination, is any uncontrolled leakage of urine.
Benign prostatic hyperplasia and Urinary incontinence · Urinary incontinence and Urinary retention ·
Urinary tract infection
A urinary tract infection (UTI) is an infection that affects part of the urinary tract.
Benign prostatic hyperplasia and Urinary tract infection · Urinary retention and Urinary tract infection ·
Urodynamic testing
Urodynamic testing or urodynamics is a study that assesses how the bladder and urethra are performing their job of storing and releasing urine.
Benign prostatic hyperplasia and Urodynamic testing · Urinary retention and Urodynamic testing ·
Urology
Urology (from Greek οὖρον ouron "urine" and -λογία -logia "study of"), also known as genitourinary surgery, is the branch of medicine that focuses on surgical and medical diseases of the male and female urinary-tract system and the male reproductive organs.
Benign prostatic hyperplasia and Urology · Urinary retention and Urology ·
5α-Reductase inhibitor
5α-Reductase inhibitors (5-ARIs), also known as dihydrotestosterone (DHT) blockers, are a class of medications with antiandrogenic effects which are used primarily in the treatment of enlarged prostate and scalp hair loss.
5α-Reductase inhibitor and Benign prostatic hyperplasia · 5α-Reductase inhibitor and Urinary retention ·
The list above answers the following questions
- What Benign prostatic hyperplasia and Urinary retention have in common
- What are the similarities between Benign prostatic hyperplasia and Urinary retention
Benign prostatic hyperplasia and Urinary retention Comparison
Benign prostatic hyperplasia has 130 relations, while Urinary retention has 110. As they have in common 42, the Jaccard index is 17.50% = 42 / (130 + 110).
References
This article shows the relationship between Benign prostatic hyperplasia and Urinary retention. To access each article from which the information was extracted, please visit: